News

Activation Capital $15,000 Pitch Contest in November to Shine Light on Virginia Businesses

The inaugural Pitch Virginia event, powered by Activation Capital, will take place on Wednesday, November 10 at the newly opened Shift Retail Lab at VCU, an initiative of the VCU da Vinci Center.  Kicking off with a design thinking workshop in the morning, the day will be filled with pitches from high growth, main street and student companies competing for $15,000 of prize money, concluding with the grand opening event of the Shift Retail Lab at VCU with a cocktail networking event and open house tours of the space in the evening.  These events are an official activity of Global Entrepreneurship Week, an international movement to empower entrepreneurs and help make it possible for anyone, anywhere to start and scale.

Pitch Virginia is an opportunity to highlight the entrepreneurs and startup companies in the Commonwealth.  The contest will feature three categories: high growth startups, main street companies, and student-owned ventures.  Capital One is sponsoring the event and donated $15,000 in cash prizes for winning companies.

Matt Briggs, VP of Capital One Card Technology and Platforms shared, “Capital One is committed to elevating the mission driven small business ecosystem in Virginia and our support for this event allows us to empower entrepreneurs at all levels – student entrepreneurs, brick and mortar businesses, and high growth startups with the potential to scale. We are looking forward to November and Pitch Virginia to bring innovative minds and ecosystem supporters together to continue developing Virginia’s small business sector.”

Speaking about Pitch Virginia, Chandra Briggman, President and CEO of Activation Capital said, “We wanted to create a new event that will cater to founders and entrepreneurs, showcasing all types of companies, and feel Pitch Virginia will be a place for people to come together for networking and community, while also supporting the entrepreneurial ecosystem in the Commonwealth.”

Companies can apply to pitch and individuals can register to attend at http://activation.capital/pitch.

Recent News

08/25/2026

United Therapeutics Corporation Announces FDA Filing Acceptance of New Drug Application for Ralinepag to Treat Pulmonary Arterial Hypertension

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the FDA has accepted the New Drug Application (NDA) for ralinepag to treat PAH. The FDA has set a Prescription Drug User Fee Act target action date of June 24, 2027. Ralinepag has not been approved for use in any indication by the

08/19/2026

ATCC Receives New CDC Award to Advance Influenza Testing and Surveillance

ATCC has been selected by the Centers for Disease Control and Prevention (CDC) for a new contract to support serological assays for the detection and characterization of influenza viruses. The award, valued at up to $7.3 million over the 5-year contract period (contract 75D30126C21030), will support CDC’s National Center for Immunization and Respiratory Diseases, Influenza

08/18/2026

Nanochon Receives Regulatory Approval from Panamá’s Ministry of Health to Initiate First-in-Human Clinical Study of Chondrograft™

Nanochon, a medical device company developing Chondrograft™, a novel patented implant for the treatment of articular cartilage defects of the knee, today announced that it has received regulatory approval from Panamá’s Ministry of Health to initiate its First-in-Human (FIH) clinical study in Panamá. The study will evaluate the safety and performance of Chondrograft™ in patients